Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Shamash

Showing results (51-60 of 110) with videos related to

Pageof 11
Sort By:
Nature Reviews. Urology|March 7, 2023
Treatment de-escalation for stage II seminomaGeorgina E Wood, Florence Chamberlain, Ben Tran, et al.
European Journal of Cancer (Oxford, England : 1990)|May 29, 2019
A phase II study of carboplatin AUC-10 guided by positron emission tomography-defined metabolic response in metastatic seminomaJonathan Shamash, Rizwan Syed, Shah-Jalal Sarker, et al.
Clinical Genitourinary Cancer|March 16, 2020
The Use of Transdermal Estrogen in Castrate-resistant, Steroid-refractory Prostate CancerKatherine Smith, Myria Galazi, Mark R Openshaw, et al.
Cancers|February 13, 2026
High Frequency Loss of 17q11.2 and Downregulation of the Cancer Metastasis Suppression microRNA miR-193a-3p in Prostate Cancer Bone MetastasisElzbieta Stankiewicz, Sarah C McCarley, Xueying Mao, et al.
European Urology|July 9, 2014
A randomised phase 2 trial of intensive induction chemotherapy (CBOP/BEP) and standard BEP in poor-prognosis germ cell tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604)Robert A Huddart, Rhian Gabe, Fay H Cafferty, et al.
Plos One|September 24, 2015
Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation SystemLei Xu, Xueying Mao, Ahmet Imrali, et al.
BJU International|June 26, 2013
Bone metastases in germ cell tumours: lessons learnt from a large retrospective studyMariam Jamal-Hanjani, Anna Karpathakis, Amy Kwan, et al.
Lung Cancer (Amsterdam, Netherlands)|May 17, 2005
Prognostic factors in mesotheliomaJeremy P C Steele, Astero Klabatsa, Dean A Fennell, et al.
International Journal of Cancer|August 8, 2007
Phase II trial of irinotecan, cisplatin and mitomycin for relapsed small cell lung cancerDean A Fennell, Jeremy P C Steele, Jonathan Shamash, et al.
Cancer|December 6, 2006
Efficacy and safety of first- or second-line irinotecan, cisplatin, and mitomycin in mesotheliomaDean A Fennell, Jeremy P C Steele, Jonathan Shamash, et al.
Pageof 11

Showing results (51-60 of 110) with videos related to

Sort By:
Pageof 11
Nature Reviews. Urology|March 7, 2023
Treatment de-escalation for stage II seminomaGeorgina E Wood, Florence Chamberlain, Ben Tran, et al.
European Journal of Cancer (Oxford, England : 1990)|May 29, 2019
A phase II study of carboplatin AUC-10 guided by positron emission tomography-defined metabolic response in metastatic seminomaJonathan Shamash, Rizwan Syed, Shah-Jalal Sarker, et al.
Clinical Genitourinary Cancer|March 16, 2020
The Use of Transdermal Estrogen in Castrate-resistant, Steroid-refractory Prostate CancerKatherine Smith, Myria Galazi, Mark R Openshaw, et al.
Cancers|February 13, 2026
High Frequency Loss of 17q11.2 and Downregulation of the Cancer Metastasis Suppression microRNA miR-193a-3p in Prostate Cancer Bone MetastasisElzbieta Stankiewicz, Sarah C McCarley, Xueying Mao, et al.
European Urology|July 9, 2014
A randomised phase 2 trial of intensive induction chemotherapy (CBOP/BEP) and standard BEP in poor-prognosis germ cell tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604)Robert A Huddart, Rhian Gabe, Fay H Cafferty, et al.
Plos One|September 24, 2015
Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation SystemLei Xu, Xueying Mao, Ahmet Imrali, et al.
BJU International|June 26, 2013
Bone metastases in germ cell tumours: lessons learnt from a large retrospective studyMariam Jamal-Hanjani, Anna Karpathakis, Amy Kwan, et al.
Lung Cancer (Amsterdam, Netherlands)|May 17, 2005
Prognostic factors in mesotheliomaJeremy P C Steele, Astero Klabatsa, Dean A Fennell, et al.
International Journal of Cancer|August 8, 2007
Phase II trial of irinotecan, cisplatin and mitomycin for relapsed small cell lung cancerDean A Fennell, Jeremy P C Steele, Jonathan Shamash, et al.
Cancer|December 6, 2006
Efficacy and safety of first- or second-line irinotecan, cisplatin, and mitomycin in mesotheliomaDean A Fennell, Jeremy P C Steele, Jonathan Shamash, et al.
Pageof 11